-- Bruce C Cozadd, Director, on May 01, 2026, sold 6,000 shares in Jazz Pharmaceuticals (JAZZ) for $1,219,980. Following the Form 4 filing with the SEC, Cozadd has control over a total of 378,682 ordinary shares of the company, with 378,682 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1232524/000119321026000011/xslF345X05/edgardoc.xml
Russel Metals (RUS.TO) after trade Tuesday reported a 67% jump in first-quarter earnings on record quarterly revenue, topping estimates.Russel posted a profit of C$72 million, or $1.30 per share, up from $43 million, or $0.75, a year earlier. In exceeded the consensus estimate of $0.76 compiled by FactSet analysts.Revenue rose 21% to to $1.41 billion, up from $1.17 billion, surpassing $1.38 billion.In the first quarter , the company also reported an EBITDA of $124 million, which was a 44% increase over the first quarter of 2025, and an 80% increase over the fourth quarter of 2025.The company's shares closed up $0.44 to $53.48 on the Toronto Stock Exchange.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CE reported Q1 2026 EPS of $0.85 vs. $0.54 in the prior year, missing consensus by $0.05, while revenue of $2.337B rose 6% sequentially but declined 2% Y/Y, missing estimates by $9M. Engineered Materials showed strong operational improvements with sales of $1.325B (+3% Y/Y) and operating margins expanding to 17% as operating profit surged to $221M from $94M, reflecting successful execution of product mix optimization and cost reduction initiatives. Management advanced structural actions including closure of the Singapore nylon facility and network enhancements across Asia and Europe. Management raised full-year FCF guidance to $700M-$800M and provided Q2 EPS guidance of $2.00-$2.40, with approximately $3.00 expected for the second half. The company targets net debt/operating EBITDA improvement to 4.8x through continued cash generation, though Q1 FCF of only $3M reflects seasonal working capital timing and highlights the importance of debt reduction given elevated leverage levels.